Alere Receives FDA CLIA Waiver for Alere(TM) i Strep A Rapid Molecular Test

Molecular diagnostic platform that detects Group A Streptococcus infections in 8 minutes or less now widely available in broad range of healthcare settings WALTHAM, Mass., July 16, 2015 -- (Healthcare Sales & Marketing Network) -- Alere Inc. (ALR), a g... Diagnostics, FDAAlere, i Strep A, Group A Streptococcus, Streptococcus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news